No Benefit to Adding Limited Radiation in Advanced Cancer :

However, a post-hoc analysis adds to evidence suggesting that irradiating all metastatic lesions may improve survival in patients receiving immune checkpoint inhibitor monotherapy.

Related Keywords

Belgium , Belgian , Mathieu Spaas , Tegen Kanker , Varian Medical Systems , Novartis , Department Of Radiation Oncology , Bristol Myers Squibb , Ghent University , Radiation Oncology , Kom Op Tegen Kanker , Varian Medical , Bristol Myers , Skin Cancer , Alignant Skin Neoplasm , Metastasis , Immunotherapy , Lung Cancer , Ung Carcinoma , Ancer Lung , Malignant Kidney Neoplasm , Kidney Cancer , Renal Cell Cancer , Renal Cell Carcinoma , Ancer Kidney , Ancer Renal Cell , Cancer , Alignant Neoplasia , Arcinoma , Palliative Care , Squamous Carcinoma , Advanced Cancer , Melanoma , Malignant Melanoma , Tumor ,